130 related articles for article (PubMed ID: 29563589)
1. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Rozmus J; Ivison S; Kariminia A; Leung VM; Sung S; Subrt P; Lee SJ; Boilard E; Walker I; Foley R; Lipton J; Gallagher G; Couban S; Schultz KR
Bone Marrow Transplant; 2018 Oct; 53(10):1263-1269. PubMed ID: 29563589
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children.
Azadpour S; Abdossamadi S; Ng B; Ostroumov E; Abroun S; Cuvelier GDE; Schultz KR
Exp Hematol; 2023 May; 121():12-17. PubMed ID: 36868452
[TBL] [Abstract][Full Text] [Related]
3. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
[TBL] [Abstract][Full Text] [Related]
5. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Poe JC; Jia W; Su H; Anand S; Rose JJ; Tata PV; Suthers AN; Jones CD; Kuan PF; Vincent BG; Serody JS; Horwitz ME; Ho VT; Pavletic SZ; Hakim FT; Owzar K; Zhang D; Blazar BR; Siebel CW; Chao NJ; Maillard I; Sarantopoulos S
Blood; 2017 Nov; 130(19):2131-2145. PubMed ID: 28851699
[TBL] [Abstract][Full Text] [Related]
6. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
[TBL] [Abstract][Full Text] [Related]
8. Elevated Cell-Free Mitochondrial DNA in Filtered Plasma Is Associated With HIV Infection and Inflammation.
Arshad O; Gadawska I; Sattha B; Côté HCF; Hsieh AYY;
J Acquir Immune Defic Syndr; 2018 May; 78(1):111-118. PubMed ID: 29630031
[TBL] [Abstract][Full Text] [Related]
9. Red Blood Cells Homeostatically Bind Mitochondrial DNA through TLR9 to Maintain Quiescence and to Prevent Lung Injury.
Hotz MJ; Qing D; Shashaty MGS; Zhang P; Faust H; Sondheimer N; Rivella S; Worthen GS; Mangalmurti NS
Am J Respir Crit Care Med; 2018 Feb; 197(4):470-480. PubMed ID: 29053005
[TBL] [Abstract][Full Text] [Related]
10. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
[TBL] [Abstract][Full Text] [Related]
11. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
14. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma levels of circulating cell-free mitochondrial DNA in suicide attempters: associations with HPA-axis hyperactivity.
Lindqvist D; Fernström J; Grudet C; Ljunggren L; Träskman-Bendz L; Ohlsson L; Westrin Å
Transl Psychiatry; 2016 Dec; 6(12):e971. PubMed ID: 27922635
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
17. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
18. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Allen JL; Fore MS; Wooten J; Roehrs PA; Bhuiya NS; Hoffert T; Sharf A; Deal AM; Armistead P; Coghill J; Gabriel DA; Irons R; Essenmacher A; Shea TC; Richards K; Cutler C; Ritz J; Serody J; Baldwin AS; Sarantopoulos S
Blood; 2012 Sep; 120(12):2529-36. PubMed ID: 22896003
[TBL] [Abstract][Full Text] [Related]
19. Increased BCR responsiveness in B cells from patients with chronic GVHD.
Allen JL; Tata PV; Fore MS; Wooten J; Rudra S; Deal AM; Sharf A; Hoffert T; Roehrs PA; Shea TC; Serody JS; Richards KL; Jagasia M; Lee SJ; Rizzieri D; Horwitz ME; Chao NJ; Sarantopoulos S
Blood; 2014 Mar; 123(13):2108-15. PubMed ID: 24532806
[TBL] [Abstract][Full Text] [Related]
20. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]